Sparks fly over marijuana legalization
Politically influential opponents of Delaware's marijuana legalization bill voiced their concerns Thursday in a roundtable conversation with Gov. John Carney and the bill's sponsors.
A gaggle of cannabis legalization activists watched on and many offered opinions during a comment session, resulting in a lively and largely measured debate about the future of marijuana in Delaware.
At question is House Bill 110, or the Delaware Marijuana Control Act, which would regulate the recreational use of less than one ounce of marijuana "in the same manner as alcohol."
Kimbo Kush (Indica)
A strain developed by Exotic Genetix, it's a 70/30 indica-dominant hybrid of Platinum Blackberry Kush and Starfighter (itself a phenotype of Tahoe Alien OG). Kimbo Kush is an excellent overall pain reliever and worked well for spasms and stress. Everything about its looks and tastes screams “indica” what with its very dark green hues and berry flavors, but there's just enough sativa in its blood to keep it from inducing sleepy-headedness. Use this one on weekends and evenings and you should get everything you need in a medicine.
Positive Effects of Medical Marijuana on Alzheimer’s Prevention
A preclinical study published in the Journal of Alzheimer’s Disease found that very small doses of tetrahydrocannabinol (THC), can slow the production of toxic clumps of beta-amyloid proteins in the brain, which are thought to kick start the progression of Alzheimer’s disease.
In a healthy brain, these protein fragments are broken down and eliminated. For those with Alzheimer’s disease, the fragments accumulate to form hard, insoluble plaques.
The study supports the results of previous research that found evidence of the protective effects of cannabinoids, including THC, on patients with neurodegenerative diseases.
Back in 2006, Kim Janda, a chemistry professor at the Scripps Research Institute in La Jolla, California, and his colleagues published the first study showing that THC might have a positive effect in fighting Alzheimer’s.
GW Pharmaceuticals Files for FDA Approval After Report Confirms Success in Treating Epilepsy
GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators.
The New England Journal of Medicine just published results from a Phase III study showing that GW’s Epidiolex (derived from cannabidiol) significantly reduced monthly convulsive seizures, especially in children with Dravet syndrome, one of the most difficult types of epilepsy to treat. Children can have dozens, even hundreds, of seizures per month.
GW Pharmaceuticals first reported in March 2016 that CBD-derived Epidiolex cut monthly convulsive seizures by 39 percent in children with Dravet syndrome, but full results of the 120-patient study were only published last week.
- 193,007 Views Category: Odd
- 152,023 Views Category: Fun
- 141,517 Views Category: Culture
- 103,709 Views Category: Culture
- 102,204 Views Category: Culture
- 101,241 Views Category: Fun
- 81,802 Views Category: Culture
- 79,965 Views Category: Odd
- 71,865 Views Category: Fun
- 65,286 Views Category: Fun